An Vermeersch graduated as Bio-Engineer in Microbiology and Biochemistry at the University of Ghent and obtained a Master of Business Administration at the Vlerick School of Management.
She started her career at GSK, after which she started working as a consultant at McKinsey & Company, Inc, in 2000 where she led several projects in Healthcare and Pharma. In 2008, she returned to GSK Vaccines as Director Global Business Operations, Global Vaccines Development. From 2012 until 2015, as Vice President, Vaccines Executive Office, she led the set-up of a new strategy, the transformation program and the integration of Novartis Vaccines. Since 2016, when she was appointed Vice President, Global Health and Corporate Affairs, she also drives the Global Health strategy.
An Vermeersch has been a board member of Gimv since June 2017.